Connor, Clark & Lunn Investment Management Ltd. Uro Gen Pharma Ltd. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
SELL
$13.81 - $19.33 $411,386 - $575,821
-29,789 Reduced 64.79%
16,188 $242,000
Q4 2023

Feb 09, 2024
BUY
$10.87 - $15.93 $176,213 - $258,241
16,211 Added 54.46%
45,977 $689,000
Q3 2023

Nov 13, 2023
BUY
$8.84 - $22.64 $73,018 - $187,006
8,260 Added 38.41%
29,766 $417,000
Q2 2023

Aug 10, 2023
BUY
$8.75 - $14.29 $188,177 - $307,320
21,506 New
21,506 $222,000

Others Institutions Holding URGN

# of Institutions
130
Shares Held
35.9M
Call Options Held
22K
Put Options Held
93.8K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $260M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email